Welcome to LookChem.com Sign In|Join Free

CAS

  • or

471239-60-8

Post Buying Request

471239-60-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

471239-60-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 471239-60-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,7,1,2,3 and 9 respectively; the second part has 2 digits, 6 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 471239-60:
(8*4)+(7*7)+(6*1)+(5*2)+(4*3)+(3*9)+(2*6)+(1*0)=148
148 % 10 = 8
So 471239-60-8 is a valid CAS Registry Number.

471239-60-8Relevant articles and documents

Novel organic dyes with anchoring group of quinoxaline-2, 3-diol and the application in dye-sensitized solar cells

Wang, Lei,Yang, Xichuan,Wang, Xiuna,Sun, Licheng

, p. 581 - 587 (2015)

Two organic quinoxaline dyes (WQ-1 and WQ-2) with a structure of quinoxaline-2, 3-diol as the electron withdrawing and anchoring group were synthesized and applied in the dye-sensitized solar cells. Fourier transform infrared spectroscopy and two other re

π-Extended Diaza[7]helicenes by Hybridization of Naphthalene Diimides and Hexa-peri-hexabenzocoronenes

Dusold, Carolin,Sharapa, Dmitry I.,Hampel, Frank,Hirsch, Andreas

supporting information, p. 2332 - 2341 (2020/12/02)

The synthesis of an unprecedented, π-extended hexabenzocorene (HBC)-based diaza[7]helicene is presented. The target compound was synthesized by an ortho-fusion of two naphthalene diimide (NDI) units to a HBC-skeleton. A combination of Diels–Alder and Scho

Synthesis of Mavatrep: A Potent Antagonist of Transient Receptor Potential Vanilloid-1

Wells, Kenneth M.,Mehrman, Steven J.,Abdel-Magid, Ahmed F.,Ferraro, Caterina,Scott, Lorraine,Zhong, Hua Marlon,Teleha, Christopher A.,Ballentine, Scott,Li, Xun,Russell, Ronald K.,Spink, Jan M.,Diamond, Craig,Youells, Scott,Zhang, Yongzheng,Tsay, Fuh-Rong,Cesco-Cancia, Sergio,Manzo, Stephen M.,Beauchamp, Derek A.

, p. 1774 - 1783 (2015/12/01)

The process development of Mavatrep (1), a potent transient receptor potential vanilloid-1 (TRPV1) antagonist, is described. The two key synthetic transformations are the synthesis of (E)-6-bromo-2-(4-(trifluoromethyl)styryl)1H-benzo[d]imidazole (4) and the Suzuki coupling of 4 with 3,3-dimethyl-3H-benzo[c][1,2]oxaborol-1-ol (5). Compound 1a was prepared in four chemical steps in 63% overall yield.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 471239-60-8